Literature DB >> 11256804

Further characterization of serum amyloid A4 as a minor acute phase reactant and a possible nutritional marker.

T Yamada1, N Miyake, K Itoh, J Igari.   

Abstract

A constitutive isotype of human serum amyloid A, serum amyloid A4 (SAA4), is distributed into plasma lipoproteins, primarily in high density lipoproteins. Its physiological function is unknown; its serum concentration has no relationship with those of other major apolipoproteins. In this study, changes in SAA4 concentrations were further characterized. Variations in healthy individuals were negligible. In subjects undergoing renal allograft transplantation, SAA4 changed in parallel with acute phase SAA, although its magnitude was not larger than a three-fold increase. This confirmed that SAA4 is a minor acute phase reactant in humans. SAA4 concentrations showed a good agreement with serum pseudocholinesterase activity in healthy subjects and patients with lowered pseudocholinesterase when patients with elevated acute phase SAA were excluded. These results suggest that SAA4 can be an indicator of nutrition or of hepatic protein synthesis in the absence of inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11256804     DOI: 10.1515/CCLM.2001.003

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

1.  Investigation of an albumin-enriched fraction of human serum and its albuminome.

Authors:  Rebekah L Gundry; Qin Fu; Christine A Jelinek; Jennifer E Van Eyk; Robert J Cotter
Journal:  Proteomics Clin Appl       Date:  2007-01-01       Impact factor: 3.494

2.  Plasma proteomic analysis to identify potential biomarkers of histologic chorioamnionitis in women with preterm premature rupture of membranes.

Authors:  Ji Eun Lee; Kisoon Dan; Hyeon Ji Kim; Yu Mi Kim; Kyo Hoon Park
Journal:  PLoS One       Date:  2022-07-07       Impact factor: 3.752

3.  Biomarkers for late-onset neonatal sepsis.

Authors:  Richard A Polin; Tara M Randis
Journal:  Genome Med       Date:  2010-09-06       Impact factor: 11.117

4.  Serum Amyloid A is not obligatory for high-fat, high-sucrose, cholesterol-fed diet-induced obesity and its metabolic and inflammatory complications.

Authors:  Ailing Ji; Andrea C Trumbauer; Victoria P Noffsinger; Hayce Jeon; Avery C Patrick; Frederick C De Beer; Nancy R Webb; Lisa R Tannock; Preetha Shridas
Journal:  PLoS One       Date:  2022-04-18       Impact factor: 3.752

5.  Reduced apolipoprotein glycosylation in patients with the metabolic syndrome.

Authors:  Olga V Savinova; Kristi Fillaus; Linhong Jing; William S Harris; Gregory C Shearer
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

6.  Influence of polymorphism on glycosylation of serum amyloid a4 protein.

Authors:  Toshiyuki Yamada; Jyunji Sato; Kazuhiko Kotani; Masafumi Tanaka
Journal:  Biochem Res Int       Date:  2014-05-15

7.  Changes in serum proteins after endotoxin administration in healthy and choline-treated calves.

Authors:  Z Yilmaz; O Eralp Inan; M Kocaturk; A T Baykal; O Hacariz; I Hatipoglu; A Tvarijonaviciute; M Cansev; J Ceron; I H Ulus
Journal:  BMC Vet Res       Date:  2016-09-20       Impact factor: 2.741

Review 8.  Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults.

Authors:  Mieke De Buck; Mieke Gouwy; Ji Ming Wang; Jacques Van Snick; Ghislain Opdenakker; Sofie Struyf; Jo Van Damme
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 9.  Proteomic research and diagnosis in bladder cancer: state of the art review.

Authors:  Jorge Luis Wilson; Mariana Pereira Antoniassi; Paula Intasqui Lopes; Hatylas Azevedo
Journal:  Int Braz J Urol       Date:  2021 May-Jun       Impact factor: 1.541

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.